June 10, 2026 · Form 4 insider transaction
Islam Khalid bought 25,000 shares of Fennec Pharmaceuticals Inc. at $8.70 per share, a transaction worth $217.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
On June 10, 2026, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.; The option is 100% vested on date of grant.